Similarly, Cheng et al. [91] demonstrated that BRPF1 might serve as a druggable target in liver cancer, where BRPF1 was involved in the regulation of cell cycle progression, senescence, and cancer stemness of hepatocellular carcinoma. The gene discussed is BRPF1; the disease is liver cancer.